A novel, topical nonsteroidal acetyl dipeptide cream demonstrates comparable effects to the topical lower midpotency steroid desonide cream on adult atopic dermatitis/eczema - 21/04/16
Maria Beatrice Alora-Palli, MD, Clinical Unit for Research Trials in Skin (CURTIS), Boston, MA, United States; Katie Shahwan, MD, Clinical Unit for Research Trials in Skin (CURTIS), Boston, MA United States; Justine Gostomski, MS, NeoStrata Company, Inc, Princeton, NJ, United States; Brenda Edison, NeoStrata Company, Inc, Princeton, NJ, United States; Yaling Lee, PhD, NeoStrata Company, Inc, Princeton, NJ, United States; Barbara Green, MS, NeoStrata Company, Inc, Princeton, NJ, United States; Alexa B. Kimball, MD, MPH, Clinical Unit for Research Trials in Skin (CURTIS), Boston, MA, United States
Le texte complet de cet article est disponible en PDF. Supported 100% by NeoStrata Company, Inc. |
Vol 74 - N° 5S1
P. AB83 - mai 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?